Palisade Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
CARLSBAD, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) a late-stage biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications, announces today that Chief Executive Officer Tom Hallam, Ph.D. will present at the H.C. Wainwright Global Investment Conference, which is being held virtually from September 13- 15, 2021.
Dr. Hallam will deliver his corporate presentation, which will become available beginning on September 13 at 7:00 AM ET.
Investors can register here: www.hcwevents.com.
Dr. Hallam will also be available for one-on-one meetings throughout the conference.
About Palisade Bio, Inc.
Forward Looking Statements
Palisade Bio Investor Relations Contact:
Palisade Bio Media Relations Contact:
Smart Street Lighting
We Only have 5 Senses, but Things have Sensors Galore
Keynote Presentation - Open to all Badge Holders